SuperworthGE HealthCare Technologies EV/EBIT GEHC
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2024.
- Today, Oct 23, 2026
- 14.7×
- 3-year median
- 16.1×
- Against its 3-year history
- 24th
- percentile: 0 is its lowest day, 100 its highest
- 3-year range
- 13.4× to 20.8×
- Peer median
- 23.4×
GE HealthCare Technologies' EV/EBIT is 14.7× as of Oct 23, 2026.
That is below its 3-year median of 16.1×, lower than on 76% of days in the last 3 years.
Over that time it ranged from 13.4× in Jul 2026 to 20.8× in Mar 2024.
The median for 9 medical device stocks of a similar size is 23.4×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 14.7× | 13.4× | 17.6× |
| 2025 | 16.9× | 13.4× | 19.2× |
| 2024 | 17.6× | 17.4× | 20.8× |
Against its peers
Companies in Medical - Devices nearest GE HealthCare Technologies' size, closest first, today.
| Company | EV/EBIT |
|---|---|
| GEHCGE HealthCare Technologies | 14.7× |
| DXCMDexCom | 25.3× |
| EWEdwards Lifesciences | 23.5× |
| ZBHZimmer Biomet | 21.5× |
| BSXBoston Scientific | 18.2× |
| SYKStryker | 23.4× |
| MDTMedtronic | 20.7× |
| ABTAbbott Laboratories | 28.2× |
| LIVNLivaNova | 22.6× |
| ITGRInteger | 29.7× |
| Peer median | 23.4× |
Where GE HealthCare Technologies ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on GE HealthCare Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.